SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001485003-21-000125
Filing Date
2021-06-03
Accepted
2021-06-03 18:43:24
Documents
4
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162276018284821.html 3  
1 FORM 3 wf-form3_162276018284821.xml 3 1734
2 PATRICIA M. DRAKE POA (HTM) sesn-limitedpowerofattor.htm EX-24 4125
3 PATRICIA M. DRAKE POA (JPG 1) sesn-limitedpowerofattor001.jpg GRAPHIC 245196
4 PATRICIA M. DRAKE POA (JPG2) sesn-limitedpowerofattor002.jpg GRAPHIC 36437
  Complete submission text file 0001485003-21-000125.txt   395482
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142
Business Address
Drake Patricia M. (Reporting) CIK: 0001865279 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 21994118